Skip to main content

Table 1 Prevalence of oqxAB genes and susceptibility to 11 antimicrobial agents

From: Prevalence and molecular characterization of oqxAB in clinical Escherichia coli isolates from companion animals and humans in Henan Province, China

Antibioticsb Isolates from Dogs (n = 106) Isolates from Cats (n = 64) Isolates from Humans (n = 100) Total
P-value
oqxAB-positive
58.5% (62//106)a
oqxAB-negative
41.5% (44//106)
oqxAB-positive
56.25% (36//64)a
oqxAB-negative
43.75% (28/64)
oqxAB-positive
42.0% (42//100)a
oqxAB-negative
58.0% (58/100)
MIC50 MIC90 R(%) MIC50 MIC90 R(%) P-value MIC50 MIC90 R(%) MIC50 MIC90 R(%) P-value MIC50 MIC90 R(%) MIC50 MIC90 R(%) P-value
COL 0.25 1 0 0.25 1 0 0.125 0.25 0 0.03 0.25 0 0.25 8 15.6 0.5 4 11.1 0.505 0.674
TET 128 >256 95.2 32 64 72.7 0.054 64 256 100 16 64 80 0.091 32 64 100 16 64 72.2 0.004 6.63 × 10−5
OLA 64 128 85.7 16 64 18.2 4.77 × 10−5 64 256 100 2 64 20 0.008 64 128 90.6 4 32 11.1 2.69 × 10−8 5.79 × 10−12
MEQ 4 64 1 4 16 64 4 16 32 128 4 16
CEF 16 64 73.8 8 32 72.7 0.608 8 32 77.3 8 64 80 0.624 128 >512 96.9 128 >512 94.4 0.595 0.745
CIP 32 >512 85.8 <0.25 4 36.4 0.002 4 32 81.8 0.25 4 30 0.007 64 >512 93.8 8 256 66.7 0.019 1.57 × 10− 6
CRO 64 >512 73.8 8 32 63.6 0.375 4 32 59.1 8 64 70 0.427 64 >512 90.6 128 >512 94.4 0.544 0.704
DOX 64 >128 88.1 8 16 54.5 0.023 32 >128 81.8 4 16 70 0.376 16 128 93.8 16 64 88.9 0.456 0.039
GAT 8 64 57.5 0.5 4 18.2 0.021 2 8 59.1 <0.25 8 30 0.127 16 64 87.5 8 64 44.4 0.001 2.47 × 10−4
AMK 32 >512 61.9 16 512 81.8 0.191 0.25 8 13.6 2 16 30 0.264 256 512 84.4 256 >512 88.9 0.505 0.144
FFC 16 128 78.6 4 128 63.6 0.257 4 16 68.2 2 16 40 0.138 128 256 87.5 64 256 66.7 0.083 0.016
  1. -, no statistical or not determined
  2. aRate of oqxAB-positive isolates; oqxAB-positive isolates/t total isolates
  3. bCOL colistin, TET tetracycline, OLA olaquindox, MEQ mequindox, CEF ceftiofur; CRO ceftriaxone, DOX doxycyclin, CIP ciprofloxacin, GAT gatifloxacin, AMK amikacin, FFC florfenicol